Morphosys Ag (MOR) has released an update.
MorphoSys AG has issued a notification of major holdings, revealing that Morgan Stanley now holds a new total of 6.79% of voting rights, combining direct shares and financial instruments. This change represents a shift from the previous notification, with direct voting rights at 4.43% and voting rights through instruments at 2.36%. The announcement underscores the evolving shareholder landscape of the German biopharmaceutical company.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.
